Health and Healthcare
Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)
Published:
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to be one of no conviction either way. Here are the short seller reports in the short interest:
Stock (Ticker) NOV. 28 NOV. 14 CHANGE
Amgen Inc. (AMGN) 23,033,081 24,169,278 -4.70%
Celgene Corporation (CELG) 8,298,820 8,040,642 +3.21%
Biogen Idec Inc. (BIIB) 8,027,848 7,938,637 +1.12%
Genzyme Corporation (GENZ) 6,569,181 6,797,501 -3.36%
Gilead Sciences (GILD) 29,055,791 30,213,915 -3.83%
Jon C. Ogg
December 10, 2008
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
